PATENT CLAIM ANALYSIS

Application Number: 16209856
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "210180"]

Abstract:
Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.

Claim (Index 66):
A compound, which is 5-(3-(Azetidin-1-ylmethyl)-6-fluoro-2-methylphenyl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 98.0
- Lexical Diversity: 1.31429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15698788', '15698768', '16045358', '15343375', '15019144']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7372985187274849
- 35 USC 102 Novelty (BERT): 0.5067282758972884
- Combined Prediction Score: 0.7142414944444652
- Mean Citation Score: 233.832758
- Max Citation Score: 271.848
- Similarity Product: 227.6214745602608

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test